News Medical on MSN4d
World first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in men
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...
Pharmabiz5d
UK MHRA approves trofolastat for diagnostic imaging of prostate cancer in men
UK MHRA approves trofolastat for diagnostic imaging of prostate cancer in men: United Kingdom Monday, March 31, 2025, 15:00 Hrs [IST] The Medicines and Healthcare products Regulat ...
pharmaphorum4d
UK first to approve Rotop's prostate cancer imaging agent
The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK said it has given a world-first approval to Rotop's ...
Open Access Government4d
MHRA approves trofolastat for prostate cancer imaging
The MHRA has approved the product for three clinical settings, including identifying how far high-risk prostate cancer has ...